Skip to main content
Log in

Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Melatonin modifies physiological and behavioral responses to psychostimulants, with the MT1 and MT2 melatonin receptors specifically implicated in facilitating methamphetamine (METH)-induced sensitization in melatonin-proficient mice.

Objective

The objective of the study is to assess differences in locomotor sensitization after a single dose of methamphetamine in low-melatonin-expressing C57BL/6 wild-type and MT1 receptor knockout (MT1KO) mice, comparing with melatonin-expressing C3H/HeN mice.

Methods

Mice received a vehicle or methamphetamine (1.2 mg/kg, i.p.) pretreatment (day 1) during the light (ZT5-9) or dark (ZT 19–21) periods in novel test arenas. Locomotor sensitization was assessed by methamphetamine challenge after an eight-day abstinence (day 9). TH protein expression was evaluated by immunofluorescence and Western blot analysis.

Results

Methamphetamine pretreatment induced statistically significant locomotor sensitization upon challenge after eight-day abstinence in C3H and C57 wild-type mice during the light period. The magnitude of sensitization in C57 mice was diminished in the dark period and completely abrogated in MT1KO mice. No differences were observed in tyrosine hydroxylase immunoreactivity in the mesolimbic dopamine system. Additional exposures to the test arenas after methamphetamine pretreatment (nights 2–6) enhanced sensitization.

Conclusions

Deletion of the MT1 melatonin receptor abolishes sensitization induced by a single METH pretreatment. The magnitude of sensitization is also altered by time of day and contextual cues. We conclude that the MT1 melatonin receptor is emerging as a novel target of therapeutic intervention for drug abuse disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Abarca C, Albrecht U, Spanagel R (2002) Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc Natl Acad Sci USA 99:9026–9030

    Article  CAS  PubMed  Google Scholar 

  • Addy NA, Daberkow DP, Ford JN, Garris PA, Wightman RM (2010) Sensitization of rapid dopamine signaling in the nucleus accumbens core and shell after repeated cocaine in rats. J Neurophysiol 104:922–931

    Article  CAS  PubMed  Google Scholar 

  • Akhisaroglu M, Ahmed R, Kurtuncu M, Manev H, Uz T (2004) Diurnal rhythms in cocaine sensitization and in Period1 levels are common across rodent species. Pharmacol, Biochem Behav 79:37–42

    Article  CAS  Google Scholar 

  • Badiani A, Anagnostaras SG, Robinson TE (1995a) The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology (Berl) 117:443–452

    Article  CAS  Google Scholar 

  • Badiani A, Browman KE, Robinson TE (1995b) Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res 674:291–298

    Article  CAS  PubMed  Google Scholar 

  • Bevins RA, Peterson JL (2004) Individual differences in rats' reactivity to novelty and the unconditioned and conditioned locomotor effects of methamphetamine. Pharmacol, Biochem Behav 79:65–74

    Article  CAS  Google Scholar 

  • Browning C, Beresford I, Fraser N, Giles H (2000) Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors. Br J Pharmacol 129:877–886

    Article  CAS  PubMed  Google Scholar 

  • Chiu CT, Ma T, Ho IK (2005) Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone. Brain Res Bull 67:100–109

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Crusio WE, Goldowitz D, Holmes A, Wolfer D (2009) Standards for the publication of mouse mutant studies. Genes Brain Behav 8:1–4

    Article  CAS  PubMed  Google Scholar 

  • Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J (2010) International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 62:343–380

    Article  CAS  PubMed  Google Scholar 

  • Dubocovich ML, Hudson RL, Sumaya IC, Masana MI, Manna E (2005) Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse. J Pineal Res 39:113–120

    Article  CAS  PubMed  Google Scholar 

  • Dudai Y (2006) Reconsolidation: the advantage of being refocused. Curr Opin Neurobiol 16:174–178

    Article  CAS  PubMed  Google Scholar 

  • Ersahin C, Masana MI, Dubocovich ML (2002) Constitutively active melatonin MT(1) receptors in male rat caudal arteries. Eur J Pharmacol 439:171–172

    Article  CAS  PubMed  Google Scholar 

  • Faith RE, Huerkamp MJ (2009) Environmental considerations for research animals. In: Hessler J, Lehner N (eds) Planning and designing research animal facilities. Elsevier, London, pp 59–83

    Chapter  Google Scholar 

  • Falcon E, McClung CA (2009) A role for the circadian genes in drug addiction. Neuropharmacology 56(Suppl 1):91–96

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Futamura T, Akiyama S, Sugino H, Forbes A, McQuade RD, Kikuchi T (2010) Aripiprazole attenuates established behavioral sensitization induced by methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 34:1115–1119

    Article  CAS  PubMed  Google Scholar 

  • Gaytan O, Lewis C, Swann A, Dafny N (1999) Diurnal differences in amphetamine sensitization. Eur J Pharmacol 374:1–9

    Article  CAS  PubMed  Google Scholar 

  • Gillette MU, Mitchell JW (2002) Signaling in the suprachiasmatic nucleus: selectively responsive and integrative. Cell Tissue Res 309:99–107

    Article  CAS  PubMed  Google Scholar 

  • Hirabayashi M, Alam MR (1981) Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice. Pharmacol, Biochem Behav 15:925–932

    Article  CAS  Google Scholar 

  • Hirabayashi M, Okada S, Tadokoro S (1991) Comparison of sensitization to ambulation-increasing effects of cocaine and methamphetamine after repeated administration in mice. J Pharm Pharmacol 43:827–830

    Article  CAS  PubMed  Google Scholar 

  • Hirata H, Asanuma M, Cadet JL (1998) Melatonin attenuates methamphetamine-induced toxic effects on dopamine and serotonin terminals in mouse brain. Synapse 30:150–155

    Article  CAS  PubMed  Google Scholar 

  • Hutchinson AJ, Hudson RL, Dubocovich ML (2012) Genetic deletion of MT(1) and MT(2) melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN mice. J Pineal Res 53:399–409

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Imbesi M, Arslan AD, Yildiz S, Sharma R, Gavin D, Tun N, Manev H, Uz T (2009) The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal ‘clock’ gene expression in striatal neurons in vitro. J Pineal Res 46:87–94

    Article  CAS  PubMed  Google Scholar 

  • Itzhak Y, Martin JL, Black MD, Ali SF (1998) Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization. Neuropharmacology 37:781–791

    Article  CAS  PubMed  Google Scholar 

  • Kaewsuk S, Sae-ung K, Phansuwan-Pujito P, Govitrapong P (2009) Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain. Neurochem Int 55:397–405

    Article  CAS  PubMed  Google Scholar 

  • Kasahara T, Abe K, Mekada K, Yoshiki A, Kato T (2010) Genetic variation of melatonin productivity in laboratory mice under domestication. Proc Natl Acad Sci USA 107:6412–6417

    Article  CAS  PubMed  Google Scholar 

  • Kongsuphol P, Mukda S, Nopparat C, Villarroel A, Govitrapong P (2009) Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells. J Pineal Res 46:199–206

    Article  CAS  PubMed  Google Scholar 

  • Kopp C, Vogel E, Rettori MC, Delagrange P, Renard P, Lesieur D, Misslin R (1999) Regulation of emotional behaviour by day length in mice: implication of melatonin. Behav Pharmacol 10:747–752

    Article  CAS  PubMed  Google Scholar 

  • Kozanian OO, Gutierrez A, Mohd-Yusof A, McDougall SA (2012) Ontogeny of methamphetamine-induced and cocaine-induced one-trial behavioral sensitization in preweanling and adolescent rats. Behav Pharmacol 23:367–379

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kurokawa K, Shibasaki M, Mizuno K, Ohkuma S (2011) Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of alpha(2)/delta-1 subunits of the voltage-gated calcium channels. Neuroscience 176:328–335

    Article  CAS  PubMed  Google Scholar 

  • Kurtuncu M, Arslan AD, Akhisaroglu M, Manev H, Uz T (2004) Involvement of the pineal gland in diurnal cocaine reward in mice. Eur J Pharmacol 489:203–205

    Article  CAS  PubMed  Google Scholar 

  • Nikaido T, Akiyama M, Moriya T, Shibata S (2001) Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine. Mol Pharmacol 59:894–900

    CAS  PubMed  Google Scholar 

  • Orsini C, Buchini F, Piazza PV, Puglisi-Allegra S, Cabib S (2004) Susceptibility to amphetamine-induced place preference is predicted by locomotor response to novelty and amphetamine in the mouse. Psychopharmacology (Berl) 172:264–270

    Article  CAS  Google Scholar 

  • Paxinos G, Franklin KB (2001) The mouse brain in stereotaxic coordinates. Academic, San Diego

    Google Scholar 

  • Paz MC, Assis MA, Cabrera RJ, Cancela LM, Bregonzio C (2011) The AT(1) angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol. Synapse 65:505–512

    Article  CAS  PubMed  Google Scholar 

  • Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192–216

    Article  CAS  PubMed  Google Scholar 

  • Rauhut AS, Bialecki V (2011) Development and persistence of methamphetamine-conditioned hyperactivity in Swiss-Webster mice. Behav Pharmacol 22:228–238

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Reiter RJ (1991) Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 79:C153–158

    Article  CAS  PubMed  Google Scholar 

  • Robinson TE, Berridge KC (2008) Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363:3137–3146

    Article  PubMed  Google Scholar 

  • Roka F, Brydon L, Waldhoer M, Strosberg AD, Freissmuth M, Jockers R, Nanoff C (1999) Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity. Mol Pharmacol 56:1014–1024

    CAS  PubMed  Google Scholar 

  • Roseboom PH, Namboodiri MA, Zimonjic DB, Popescu NC, Rodriguez IR, Gastel JA, Klein DC (1998) Natural melatonin ‘knockdown’ in C57BL/6J mice: rare mechanism truncates serotonin N-acetyltransferase. Brain Res Mol Brain Res 63:189–197

    Article  CAS  PubMed  Google Scholar 

  • Shen X, Purser C, Tien LT, Chiu CT, Paul IA, Baker R, Loh HH, Ho IK, Ma T (2010) mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization. J Neurosci Res 88:2294–2302

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Soares JM Jr, Masana MI, Ersahin C, Dubocovich ML (2003) Functional melatonin receptors in rat ovaries at various stages of the estrous cycle. J Pharmacol Exp Ther 306:694–702

    Article  CAS  PubMed  Google Scholar 

  • Stewart J, Badiani A (1993) Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4:289–312

    CAS  PubMed  Google Scholar 

  • Suwanjang W, Phansuwan-Pujito P, Govitrapong P, Chetsawang B (2010) The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells. J Pineal Res 48:94–101

    Article  CAS  PubMed  Google Scholar 

  • Takino N, Sakurai E, Kuramasu A, Okamura N, Yanai K (2009) Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice. Int Rev Neurobiol 85:109–116

    CAS  PubMed  Google Scholar 

  • Torres-Farfan C, Seron-Ferre M, Dinet V, Korf HW (2006) Immunocytochemical demonstration of day/night changes of clock gene protein levels in the murine adrenal gland: differences between melatonin-proficient (C3H) and melatonin-deficient (C57BL) mice. J Pineal Res 40:64–70

    Article  CAS  PubMed  Google Scholar 

  • Uz T, Akhisaroglu M, Ahmed R, Manev H (2003) The pineal gland is critical for circadian Period1 expression in the striatum and for circadian cocaine sensitization in mice. Neuropsychopharmacology 28:2117–2123

    CAS  PubMed  Google Scholar 

  • Uz T, Javaid JI, Manev H (2002) Circadian differences in behavioral sensitization to cocaine: putative role of arylalkylamine N-acetyltransferase. Life Sci 70:3069–3075

    Article  CAS  PubMed  Google Scholar 

  • Valjent E, Bertran-Gonzalez J, Aubier B, Greengard P, Herve D, Girault JA (2010) Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol. Neuropsychopharmacology 35:401–415

    Article  CAS  PubMed  Google Scholar 

  • Vezina P (2004) Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev 27:827–839

    Article  CAS  PubMed  Google Scholar 

  • von Gall C, Lewy A, Schomerus C, Vivien-Roels B, Pevet P, Korf HW, Stehle JH (2000) Transcription factor dynamics and neuroendocrine signalling in the mouse pineal gland: a comparative analysis of melatonin-deficient C57BL mice and melatonin-proficient C3H mice. Eur J Neurosci 12:964–972

    Article  Google Scholar 

  • Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Iwona Stepien, Kathleen McGowan, and Peter Crombe for their capable assistance with animal management and genotyping, and equipment maintenance.

Author contributions

All authors contributed to the conception, design, planning, data acquisition, and/or analysis of these studies. AJH drafted the manuscript which was revised and edited with substantial feedback from all authors. All authors approved the final version of the manuscript before submission.

Conflict of interest

This work was funded by R01DA021870 to MLD. The authors declare that over the last three years, MLD was a consultant for and received compensation from Takeda Pharmaceutical North America Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Margarita L. Dubocovich.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplemental Figure 1

Locomotor Responses in C57 Mice Subjected to Six Daily VEH or METH Pretreatments. Experimental protocol is shown in Panel A. Ordinates on the line graphs represent distance traveled (mean ± SEM) in 2h tests as a function of Pretreatment Day (B) and in 5 min intervals as a function of time during the challenge test on Day 11 (C). *p < 0.05 when compared to VEH; ns denotes not significant. (JPEG 56 kb)

High resolution image (TIFF 185 kb)

Supplemental Figure 2

TH Immunofluorescence in the Mesolimbic Dopamine System of C57 WT and MT1KO Mice. Representative images show CPu, NAc core, NAc shell and VTA for C57 WT (A–D) and MT1KO mice (E–H). TH protein expression was evaluated by fluorescence intensity (mean gray value, mean ± SEM) in the CPu, NAc core and NAc shell (I–K). Density of TH-positive cell bodies (mean ± SEM) was assessed in the VTA (L). Scale bar in Panel A corresponds to all CPu and NAc images. No significant (ns) differences were found between WT (n = 4) and MT1KO mice (n = 4). (JPEG 63 kb)

High resolution image (TIFF 15615 kb)

Supplemental Figure 3

TH Protein Levels in the Mesolimbic Dopamine System. Western blot analysis of brain homogenates from C57 WT (n = 8) and MT1KO mice (n = 8). Representative blot images are shown for CPu (A), NAc (B) and VTA (C) with corresponding semiquantitative densitometry analyses. Ordinates represent relative mean ± SEM of TH band intensity normalized to corresponding GAPDH values. No significant (ns) differences were observed between genotypes. (JPEG 42 kb)

High resolution image (TIFF 424 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hutchinson, A.J., Ma, J., Liu, J. et al. Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice. Psychopharmacology 231, 257–267 (2014). https://doi.org/10.1007/s00213-013-3228-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-013-3228-0

Keywords

Navigation